26 Jul Doctor Jon Cartu Announced – Researchers Launch First Study of In Vivo CRISPR Therapy in Human…
[ad_1] People with a rare form of inherited blindness are being enrolled for the world’s first in vivo study of a CRISPR-based therapy, the Associated Press reported yesterday (July 25). The experimental treatment, developed by Massachusetts-based genome-editing company Editas Medicine and Ireland-based pharmaceutical firm...